Summary
Sera of 17 patients with Wilson's disease and of 48 relatives were investigated as to a possible correlation between ceruloplasmin phenotypes and Wilson's disease. The control group included 727 healthy subjects. The results of the quantitative determination of ceruloplasmin confirmed the overlapping in the groups of so-called heterozygotes and controls known from the literature. The ceruloplasmin phenotypes in starch gel electrophoresis we observed were of the most common phenotype Cp BB in the patients as well as in the controls. Therefore, patients with Wilson's disease also show the normal Cp-phenotypes.
Zusammenfassung
Es wurden Seren von 17 Patienten mit Wilsonscher Krankheit und von 48 ihrer Verwandten im Hinblick auf eine mögliche Korrelation zwischen Cäruloplasmin-Phänotypen und der Wilsonschen Krankheit untersucht. Als Kontrollen dienten 727 gesunde Personen. Die quantitative Cäruloplasmin-Bestimmung bestätigte die aus der Literatur bekannte Überlappung der sog. Heterozygoten und Kontrollpersonen. Bezüglich der Cäruloplasmin-Phänotypen wurde bei Patienten, ihren Verwandten und den Kontrollpersonen ausschließlich der häufigste Phänotype BB in der Stärkegelelektrophorese gefunden; Patienten mit Wilson-Krankheit besitzen also normale Cp-Phänotypen.
Literatur
Alper, C.A., Propp, R.P.: Genetic polymorphism of the third component of human complement (C3). J. Clin. Invest.47, 2181–2191 (1968)
Anzil, A.P.: Primary defect in hepatolenticular degeneration. Brit. Med. J. 5912, 225–226 (1974)
Arima, M., Sano, I.: Genetic studies of Wilson's disease in Japan. Birth defects Orig. Art. Series Vol. IV, 54–59 (1968)
Arioka, I., Yanai, J., Sano, I., Ogita, Z., Kikkawa, H.: Immunochemical studies on Wilson's disease. Clin. Chim. Acta12, 353–358 (1965)
Bajatzadeh, M., Walter, H.: Studies on the population genetics of the ceruloplasmin polymorphism. Humangenetik8, 134–136 (1969)
Bearn, A.G.: A genetical analysis of thirty families with Wilson's disease (hepatolenticular degeneration). Ann. hum. Genet.24, 33–43 (1960)
Bucknall, W.E., Haslam, R.H.A., Holtzman, N.A.: Kinky hair syndrome: Response to copper therapy. Pediatrics52, 653–657 (1973)
Cox, D.W., Fraser, F.C., Sass-Kortsak, A.: A genetic study of Wilson's disease: Evidence for heterogeneity. Amer. J. hum. Genet.24, 646–666 (1972)
Deiss, A., Lynch, R.E., Lee, G.R., Cartwright, G.E.: Long-term therapy of Wilson's disease. Ann. Int. Med.75, 57–65 (1971)
Evans, G.W., Dubois, R.S., Hambidge, K.M.: Wilson's disease: Identification of an abnormal copper-binding protein. Science 181, 1175–1176 (1973). Discussion I.H. Scheinberg ibid. pp 1184–1185
Freeman, Sh., Daniel, E.: Dissociation and reconstitution of human ceruloplasmin. Biochemistry12, 4806–4810 (1973)
Hirschman, Sh.Z., Morell, A.G., Scheinberg, I.H.: The heterogeneity of the copper-containing protein of human plasma, ceruloplasmin. Ann. N.Y. Acad. Sci.94, 960–969 (1961)
Holtzman, N.A., Naughton, M.A., Iber, F.L., Gaumnitz, B.M.: Ceruloplasmin in Wilson's disease. J. Clin. Invest.46, 993–1002 (1967)
Kalow, W., Genest, W.A.: A method for the detection of atypical forms of human serum cholinesterase. Determination of Dibucaine numbers. Canad. J. Biochem.35, 339–346 (1957)
Kellermann, G., Walter, H.: On the population genetics of ceruloplasmin polymorphism. Humangenetik15, 84–86 (1972)
Lange, J.: Eisen, Kupfer und Eiweiß am Beispiel der Leberkrankheiten unter besonderer Berücksichtigung der Hämochromatose und der Hepatocerebralen Degeneration. Thieme-Verlag (1958)
Lange, J.: Die Langzeitbehandlung des Morbus Wilson mit D-Penicillamin. Ein Bericht über 20 Fälle. Dtsch. Med. Wschr.92, 1657–1662 (1967)
Mancini, G., Carbonara, A.O., Heremans, J.F.: Immunochemical quantitation of antigens by single radial Immunodiffusion. Immunochemistry2, 235–238 (1965)
Martin, G., McAlister, R., Pelter, W., Benditt, E.P.: Heterogeneity of ceruloplasmin. Proc. 2nd. Intern. Congr. Hum. Genet.2, 752–756 (1961)
Mondorf, A.W., Mackenrodt, G., Halberstadt, E.: Coeruloplasmin. Klin. Wschr.49, 61–70 (1971)
Needleman, S.B., Sahgal, V., Boshes, B.: Studies on the biochemical characterization of human ceruloplasmin. Experientia26, 495–496 (1970)
Neifakh, S.A., Monakhov, N.K., Shaposhnikov, A.M., Zubshitski, Yu.N.: Localization of ceruloplasmin biosynthesis in human and monkey liver cells and its copper regulation. Experientia25, 337–344 (1969)
Owen, J.A., Smith, H.: Detection of ceruloplasmin after zone electrophoresis. Clin. Chim. Acta6, 441–443 (1961)
Poulik, M.D.: Starch gel electrophoresis in a discontinuous system of buffer. Nature (London)180, 1477–1479 (1957)
Richterich, R., Gautier, E., Stillhart, H., Rossi, E.: The heterogeneity of caeruloplasmin and the enzymatic defect in Wilson's disease. Helv. Paediat. Acta15, 424–436 (1960)
Rydén, L.: Single-chain structure of human ceruloplasmin. Eur. J. Biochem.26, 380–386 (1972)
Sass-Kortsak, A.: Hepatolenticular degeneration (Kinnier Wilson's disease) Handb. Inn. Med. 7. Band, 1. Teil, 5. Aufl., 627–665, Springer: Berlin-Heidelberg (1974)
Scheinberg, I.H., Sternlieb, I.: Wilson's disease and the concentration of caeruloplasmin in serum. Lancet1, 1420–1421 (1963)
Scheinberg, I.H., Sternlieb, I.: The bases of clinical heterogeneity of Wilson's disease. III. Symposium Mal. de Wilson, Paris (1973)
Shokeir, M.H.K., Shreffler, D.C., Gall, J.C.: Further electrophoretic variation in human ceruloplasmin. Meeting Am. Soc. Hum. Genet. Toronto (1967)
Shokeir, M.H.K.: Is ceruloplasmin a physiological ferroxidase? Clin. Biochem.5, 115–120 (1972)
Shokeir, M.H.K.: The molecular structure of human ceruloplasmin: A proposed model. Clin. Biochem.6, 9–14 (1973)
Shreffler, D.C., Brewer, G.J., Gall, I.C., Honeyman, M.S.: Electrophoretic variation in human serum ceruloplasmin: a new genetic polymorphism. Biochem. Genet.1, 101–115 (1967)
Sternlieb, I., Scheinberg, I.H.: Prevention of Wilson's disease in asymptomatic patients. New Engld. J. Med.278, 352–359 (1968)
Sternlieb, I., Van den Hamer, C.J.A., Morell, A.G., Alpert, S., Gregoriadis, G., Scheinberg, I.H.: Lysosomal defect of hepatic copper excretion in Wilson's disease (Hepatolenticular degeneration). Gastroenterology64, 99–105 (1973)
Strickland, G.T., Frommer, D., Leu, M.-L., Pollard, R., Sherlock, S., Cumings, J.N.: Wilson's disease in the United Kingdom and Taiwan. Quart. J. Med. New SeriesXLII, 619–638 (1973)
Tschumi, A., Colombo, J.P., Moser, H.: Die Wilsonsche Krankheit in der Schweiz. Klinische, genetische und biochemische Untersuchungen. Schweiz. Med. Wschr.103, 89–95 und 140–145 (1973)
Walshe, J.M., Briggs, J.: Caeruloplasmin in liver disease. A diagnostic pitfall. Lancet2, 263–265 (1962)
Walshe, J.M.: wilson's disease: its diagnosis and managmeent. Brit. J. Hosp. Med. 90–98 (1970)
Weiner, C.: Morbus Wilson im Kindesalter (Hepatocerebrale Degeneration) Münch. Med. Wschr.106, 387–402 (1964)
Young, S.N., Curzon, G.: Neonatal human caeruloplasmin. Biochim. Biophys. Acta336, 306–308 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goedde, H.W., Benkmann, H.G., Lange, J. et al. Quantitative Bestimmung und Phänotypisierung des Cäruloplasmins bei Morbus Wilson. Klin Wochenschr 53, 731–734 (1975). https://doi.org/10.1007/BF01468706
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01468706